Daily Briefing: Isomorphic Labs Takes AI-Designed Drugs to Human Trials

Isomorphic Labs, the Google DeepMind spinout focused on drug discovery, announced at WIRED Health that AI-designed drug candidates are advancing to human clinical trials — described as a 'broad and exciting pipeline' rather than a single molecule. This marks a genuine threshold crossing from computational prediction to real-world biological testing, though the historical 90% failure rate of clinical trials means reaching trials and producing effective drugs remain very different achievements. The episode also covers OpenAI's GPT-5.5 release with unified Codex, DeepSeek V4's Huawei chip compatibility, Meta's massive CPU deal with Amazon, and Deezer's disclosure that 44% of daily uploads are AI-generated.

STORIES COVERED

Isomorphic Labs says A ...